Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions. This is a stunning gut-brain breakthrough.

The gene most strongly correlated with Alzheimer's disease also boosts seizure activity by decreasing levels of ion pumps and energy-producing enzymes in neurons, a new study by researchers at the ...

Nugevia™ supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight loss Jupiter ...

A 2025 study of adults with type 2 diabetes found that more than 20 percent of participants had nutritional deficiencies ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

Aimee Donnellan has been a correspondent for Reuters since 2017. Her patch includes the pharmaceutical industry. Off the ...

An anti-doping group is keeping a close eye on the use of these obesity and diabetes drugs in elite athletes. Here’s why.

A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers. Current human data do not show a link between GLP-1 ...

Trends shaping GLP-1 landscape include FDA regulatory updates, rapid oral drug adoption, and shifting clinical evidence for diabetes care.

Australian researchers warn GLP-1 weight-loss drugs may cause scurvy, the historic "pirate disease," due to poor nutrition and vitamin C deficiency risks.

Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric ...

Doctors are recommending these three peptides as possible solutions to a number of longevity issues — from cell rejuvenation to metabolic health and risk of heart disease.